Beiersdorf, DE0005200000

Beiersdorf stock: Jefferies lifts target to EUR 78, keeps Hold

Published on 11/17/2026 at 10:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Beiersdorf stock faces a cautious outlook despite a higher target from Jefferies. The broker sees scope for Nivea recovery as retail inventories normalize.

Jefferies sees cautious recovery path

  • Jefferies expects retail inventory clearing to support a possible Nivea recovery in 2027.
  • Medical skin care remains the analyst's main growth driver for Beiersdorf.
  • Jefferies remains cautious on the group's operating margin outlook.
Beiersdorf, DE0005200000, Illustration mit AI erstellt.

Jefferies raised its price target for Beiersdorf from EUR 74 to EUR 78 on Monday, November 16, while retaining a Hold rating. The assessment was reported by dpa-AFX via wallstreetONLINE.

Analyst David Hayes adjusted his estimates after Beiersdorf's latest quarterly report. He expects the Nivea brand to have room for a recovery next year as retailers' inventory reduction is likely to be largely complete. If consumer demand improves, retailer orders could also pick up, according to the analysis.

Medical skin care remains central

Jefferies continues to identify Beiersdorf's medically oriented skin care business as the group's main growth driver. That view offsets the more cautious assessment of Nivea and reflects the different operating trends within the portfolio.

The higher target does not change the broker's overall stance. Hayes remains skeptical about the operating margin, indicating that a potential improvement in retail demand may not translate into a comparable recovery in profitability.

Share price remains below target

Beiersdorf stock traded at 83.36 euros on Lang & Schwarz at 10:30 CET on Tuesday, November 17, 0.41 percent below the Xetra close of Monday, November 16. The Jefferies target therefore remains below the current Lang & Schwarz quote, despite the increase from the previous target.

For investors, the assessment leaves two issues in focus: whether Nivea can regain momentum once retail inventories normalize and whether the medical skin care business can continue to support group growth. The margin outlook remains the main constraint in Jefferies' view.

Beiersdorf market facts

  • Company: Beiersdorf AG
  • ISIN: DE0005200000
  • Analyst: Jefferies, David Hayes
  • Rating: Hold
  • Price target: EUR 78, previously EUR 74
  • Lang & Schwarz quote: EUR 83.36 on November 17, 2026, at 10:30 CET
  • Xetra close: EUR 83.70 on November 16, 2026

Beiersdorf's next scheduled results are due on March 4, 2027, according to the company's investor calendar referenced on its stock topic page.

German equities traded in a weaker DAX environment. Current market reports provide the broader index context.

More news and analyses on Beiersdorf stock

Disclaimer...
en | DE0005200000 | BEIERSDORF | boerse | 70525896 | bgmi